ArticleJournal of nanobiotechnology2024

Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii.

Xing Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.